Innovating Works

JAMON SALAMANCA, S.A.

Inactiva
Hemstem: Targeting leukaemia by modulating hematopoietic stem cell competitiveness EBERHARD KARLS UNIVERSITAET TUEBINGEN tramitó un H2020: ERC-2019-COG Human acute myeloid leukemia (AML) remains a devastating disease with less than 30% of patients surviving five years after diagnosis. Despit...
2020-02-25 - 2025-12-31 | Financiado
ReSuNiCo: Inverted Reactive Spray Processes for Sulphide Nitride High Surface Area Electrode Coatings UNIVERSITAET BREMEN tramitó un H2020: ERC-2017-ADG Highly pure, binary and ternaty metal sulphides/nitrides are increasingly important materials for energy storage, electrocatalysis, optoelec...
2018-05-02 - 2025-06-30 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.